Zacks Industry Outlook Highlights Aflac, Unum Group, Globe Life and Trupanion
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – December 3, 2025 – Today, Zacks Equity Research discusses Aflac Inc. AFL, Unum Group UNM, Globe Life. GL and Trupanion TRUP.Industry: Health InsuranceLink: https://www.zacks.com/commentary/2798474/4-accident-health-insurers-to-watch-amid-rising-medical-costsThe Zacks Accident and Health Insurance industry is expected to benefit from an increase in underwriting exposure. Aflac Inc., Unum Group, Globe Life. and Trupanion are expected to be driven by prudent underwriting standards. However, higher inflation, as well as rising medical costs, could offset the positives. The industry has been witnessing soft pricing over the past several quarters, and this is not expected to change anytime soon. Nonetheless, a rise in claims of lower severity is likely to favor pricing. Also, the increasing adoption of technology in operations will help the industry function smoothly. The industry is witnessing a rise in demand for embedded insurance and supplemental health products.Per a CBIZ report, the industry has maintained its profitability streak, reflecting solid reserves, prudent claims management, stable loss trends and fewer claims.About the IndustryThe Zacks Accident and Health (A&H) Insurance industry comprises companies providing workers' compensation insurance, mainly to employers operating in hazardous industries. They offer group, individual or voluntary supplemental insurance products. Workers' compensation is a form of accident insurance paid by employers without affecting employees' pay.Claims are generally met by insurers or state-run workers' compensation funds, benefiting both employers and employees. While it boosts employees' morale and, in turn, productivity, employers stand to benefit from lower claim costs. As awareness about the benefits of having such coverage rises, the future of these insurers seems bright. Per Business Research Insight, the A&H Insurance market, worth about $300 billion in 2024, is projected to grow to about $420 billion in 2033, at a CAGR of 3.8%.3 Trends Shaping the Future of the Accident & Health Insurance IndustryPricing Pressure to Continue: The workers' compensation industry has been witnessing pricing pressure over the past several quarters. Inflation, coupled with rising medical costs and demographic changes, will likely continue to put pressure on pricing. While recent Fed reports state that inflation is expected to stay at 2.7% this year, per a Leavitt Group report, the Centers for Medicare and Medicaid predicts healthcare spending to increase by 5.4% each year through 2028. Given rising medical costs, the need for supplemental health plans is on the rise.Per a report in Commercial Risks, AM Best expects sustained favorable loss development and beneficial loss frequency to put downward pressure on pricing. Efforts to retain market share will further increase pricing pressure, which might curb top-line growth. With commercial and industrial activities back on track, demand for insurance coverage is likely to rise. SpendEdge estimates that workers' compensation insurance pricing will increase at a five-year (2022-2026) CAGR of 5.3%. Also, per a CBIZ report, workers' compensation pricing is expected to rise 2%.Improvement in Claims Frequency: The adoption of safety measures and improvement in working conditions are lowering claims. The accident and health insurance space has witnessed growth over the years, primarily driven by an increase in benefits offered by employers. The right kind of workers' compensation policy translates into personal care for injured workers, increased productivity, higher employee morale, lower turnover, reduced claims costs and less financial worry amid rising medical costs.Increasing underwriting exposure and a consistent decrease in claims frequency rates, attributable to a better working environment and conservative reserve levels, have been boosting the industry's performance. Per the Bureau of Labor Statistics, in the next 10 years, the number of workers aged 75 and more is expected to increase by 96.5%. Thus, claims could rise, given an increase in work-life span and the degree of severity, the report states.Increasing Adoption of Technology: The industry is witnessing accelerated adoption of technology in operations, including the use of artificial intelligence. AI, data analytics, automation, cloud computing and blockchain should help insurers gain a competitive edge. Telemedicine is also gaining traction. Machine learning and predictive analytics enable real-time risk profiling. Policies are increasingly bundling telehealth services. Per a CBIZ report, industry data reveals that artificial intelligence could reduce workers' compensation claim expense by about 45%. Nonetheless, higher spending on technological advancements will result in escalated expense ratios.Zacks Industry Rank Indicates Weak ProspectsThe group's Zacks Industry Rank, which is basically the average of the Zacks Rank of all member stocks, indicates bleak near-term prospects. The Zacks Accident and Health Insurance industry, housed within the broader Zacks Finance sector, currently carries a Zacks Industry Rank #190, which places it in the bottom 22% of the 251 Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.The industry's position in the bottom 50% of the Zacks-ranked industries is a result of a negative earnings outlook for the constituent companies in aggregate.Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually losing confidence in this group's earnings growth potential.Before we present a few stocks one can have in their portfolio, given their business advancement endeavors, it's worth taking a look at the industry's performance and current valuation.Industry Underperforms Sector and S&P 500The Accident and Health Insurance industry has underperformed its sector and the Zacks S&P 500 composite year to date. The stocks in this industry have collectively gained 5.1% year to date compared with the Finance sector's increase of 14.2% and the Zacks S&P 500 composite's increase of 18.2% over the same period.Current ValuationOn the basis of a trailing 12-month price-to-book (P/B), commonly used for valuing insurance stocks, the industry is currently trading at 1.72X compared with the Zacks S&P 500 composite's 8.47X and the sector's 4.18X.Over the past five years, the industry has traded as high as 2.14X, as low as 0.93X and at the median of 1.74X.4 Accident & Health Insurance Stocks in FocusWe are presenting four Zacks Rank #3 (Hold) stocks from the Zacks Accident and Health Insurance industry. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Aflac: This Columbus, GA-based company offers voluntary supplemental health and life insurance products and operates through Aflac Japan and Aflac U.S. The top line benefits from strategic growth investments, robust persistency rates and enhanced productivity. Aflac introduces products and upgrades existing ones to address the changing needs of its customers, as well as integrates digital solutions into its offerings to align with the ongoing trend of digitization.This, in turn, should support its profit margins. The Argus buyout will provide it with a platform to build the company's network of dental and vision products and further strengthen its U.S. segment.AFL delivered a trailing four-quarter earnings surprise of 9.38% on average. Though the Zacks Consensus Estimate for 2026 implies a year-over-year decrease of 0.1%, it has moved up 0.1% in the past 30 days. The expected long-term earnings growth rate is pegged at 4.6%.Unum Group: Chattanooga, TN-based Unum Group provides long-term care insurance, life insurance, employer- and employee-paid group benefits and related services. This insurer is poised to grow on the operational excellence of Unum U.S. and Colonial Life. Encouraging sales trends, strong persistency in group lines and growth of new product lines like dental and vision, coupled with favorable risk results, should benefit Unum U.S. and Colonial Life, the two largest operating segments. The company has an impressive dividend track record, having increased dividends 15 times in the last 14 years and yielding better than the industry average. It estimates a 10-15% increase in dividends going forward.For 2025, Unum Group expects premium growth in the band of 3-6% and adjusted operating return on equity (ROE) between 21% and 23% from the core business. UNM expects after-tax adjusted operating income per share of approximately $8.50. Unum Group expects core operations sales in 2025 to be relatively consistent with the previous year. For the long term, Unum Group expects sales growth in the range of 8-12%, premium growth in the range of 4-7% and adjusted operating earnings per share growth between 8% and 12%.The expected long-term earnings growth rate for Unum Group is 6%, better than the industry average of 5.4%. The Zacks Consensus Estimate for 2026 earnings indicates a year-over-year increase of 10.3%.Globe Life: Based in McKinney, TX, Globe Life is an insurance holding company providing individual life and supplemental health insurance to lower-middle to middle-income households throughout the United States. Globe Life has been witnessing a positive trend in revenues, driven by premium growth in its Life Insurance and Health Insurance segments and net investment income.The strong performance of the American Income and Liberty National divisions should drive the top line in the future. Liberty National is likely to continue to benefit from improved productivity and agent count. GL's expansion initiatives to capture heavily populated and less penetrated areas should drive growth in the future. Net life sales, as well as net health sales, are expected to grow in the mid-teens for Liberty National.GL delivered a trailing four-quarter earnings surprise of 0.65% on average. The Zacks Consensus Estimate for 2026 earnings indicates a 3.1% year-over-year increase. The consensus estimate for 2026 earnings has moved up 1 cent in the past 30 days.Trupanion: Headquartered in Seattle, WA, Trupanion is a provider of insurance for cats and dogs in the United States, Canada, Continental Europe and Australia. It operates in a total addressable market worth $34.1 billion, which is a large but underpenetrated market. This pet insurer is well-poised to grow, courtesy of its heightened focus on pets' health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position. This pet insurer continues to invest in areas where it believes it can achieve high internal rates of return. Improving pricing should add to its upside.The Zacks Consensus Estimate for 2026 suggests a 9.4% increase on a year-over-year basis. TRUP delivered a trailing four-quarter earnings surprise of 235.42%, on average. It has a Growth Score of A. The consensus estimate for 2026 earnings has moved 42.9% north in the past 30 days.Free: Instant Access to Zacks' Market-Crushing StrategiesSince 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.Get all the details here >>Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis Report Unum Group (UNM): Free Stock Analysis Report Trupanion, Inc. (TRUP): Free Stock Analysis Report Globe Life Inc. (GL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Aflac und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Aflac
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Aflac Inc
Analysen zu Aflac Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.03.2018 | Aflac Equal Weight | Barclays Capital | |
| 03.07.2017 | Aflac Equal Weight | Barclays Capital | |
| 01.05.2017 | Aflac Underperform | RBC Capital Markets | |
| 02.02.2017 | Aflac Underperform | RBC Capital Markets | |
| 09.12.2016 | Aflac Underperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.05.2012 | Aflac outperform | RBC Capital Markets | |
| 14.05.2012 | Aflac overweight | Barclays Capital | |
| 27.04.2012 | Aflac sector outperform | Scotia Capital Markets | |
| 26.04.2012 | Aflac outperform | RBC Capital Markets | |
| 27.03.2012 | Aflac overweight | Barclays Capital |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.03.2018 | Aflac Equal Weight | Barclays Capital | |
| 03.07.2017 | Aflac Equal Weight | Barclays Capital | |
| 10.05.2016 | Aflac Mkt Perform | FBR Capital | |
| 27.04.2016 | Aflac Neutral | UBS AG | |
| 27.04.2016 | Aflac Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.05.2017 | Aflac Underperform | RBC Capital Markets | |
| 02.02.2017 | Aflac Underperform | RBC Capital Markets | |
| 09.12.2016 | Aflac Underperform | RBC Capital Markets | |
| 09.01.2012 | Aflac sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen